The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...
FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...
AstraZeneca, said. “For more than 20 years, FLUMIST has been the only nasal spray flu vaccine licensed in the US and now it ...
The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
The AstraZeneca vaccine FluMist, which is administered in nasal spray form, was first approved by the FDA in 2003 for people ...
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.